Brain iron dysregulation and the risk of ageing white matter lesions

Ola H Gebril1, J E Simpson, Janine Kirby

  • 1Human Genetics Department, Medical Division, National Research Centre, Dokki, Cairo, Egypt. olahossny@hotmail.com

Neuromolecular Medicine
|October 8, 2011
PubMed

Insights

Increased iron in white matter lesions (WML) correlates with oxidative stress in aging brains. This study investigated iron metabolism changes, finding altered iron regulation proteins and gene expression in WML, potentially driving lesion development.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • White matter lesions (WML) are common in older adults, associated with cognitive decline, depression, and motor impairment.
  • While vascular factors are implicated, increased reactive oxygen species (ROS) production, potentially driven by iron, may contribute to WML development.
  • Understanding iron's role in WML pathogenesis is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To investigate alterations in iron levels, iron-regulating proteins, and gene expression in WML.
  • To determine the cellular localization of key iron-related proteins in affected brain tissue.
  • To correlate iron metabolism changes with the presence and severity of WML.

Main Methods:

  • Analysis of ferric iron staining in WML, normal-appearing white matter adjacent to lesions (NAWM(L)), and normal white matter (NAWM(C)).
  • Immunohistochemistry (IHC) for ceruloplasmin (Cp), hemochromatosis (HFE), and transferrin receptor (TfR), with dual-antibody IHC for cellular localization.
  • Quantitative PCR (QPCR) to assess mRNA expression of iron metabolism genes (HFE, TF, TfR, ceruloplasmin, ferritin, ferroportin).

Main Results:

  • Increased diffuse ferric iron staining was observed in WML, followed by NAWM(L), and least in NAWM(C).
  • Immunohistochemistry revealed increased HFE and Cp expression in lesional white matter, with TfR showing no significant changes.
  • mRNA expression patterns indicated decreased intracellular iron influx, increased ferrous oxidation, and enhanced iron export.

Conclusions:

  • Iron metabolism is significantly altered in brains with WML.
  • Elevated elemental iron in WML may potentiate ROS production, contributing to lesion development.
  • These findings highlight iron dysregulation as a potential factor in the pathogenesis of age-related WML.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...